Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Bacteriology

The Streptococcus milleri Population of a Cystic Fibrosis Clinic Reveals Patient Specificity and Intraspecies Diversity

Christopher D. Sibley, Kristen A. Sibley, Tara A. Leong, Margot E. Grinwis, Michael D. Parkins, Harvey R. Rabin, Michael G. Surette
Christopher D. Sibley
1Department of Microbiology and Infectious Diseases
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristen A. Sibley
1Department of Microbiology and Infectious Diseases
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tara A. Leong
1Department of Microbiology and Infectious Diseases
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margot E. Grinwis
1Department of Microbiology and Infectious Diseases
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael D. Parkins
1Department of Microbiology and Infectious Diseases
2Department of Medicine
3Adult Cystic Fibrosis Clinic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harvey R. Rabin
1Department of Microbiology and Infectious Diseases
2Department of Medicine
3Adult Cystic Fibrosis Clinic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael G. Surette
1Department of Microbiology and Infectious Diseases
4Department of Biochemistry and Molecular Biology, University of Calgary, 3330 Hospital Drive NW, Calgary, Alberta, Canada T2N 4N1
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: surette@ucalgary.ca
DOI: 10.1128/JCM.00414-10
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

The genetic relatedness of Streptococcus milleri group isolates from the airways of cystic fibrosis patients was determined by using pulsed-field gel electrophoresis. This study reveals no evidence for patient-to-patient transmission in our patient population; however, within individual patients, complex inter- and intraspecies diversity and dynamics can be observed.

In addition to their role in purulent infections (3, 7, 11), members of the Streptococcus milleri group (SMG), also known as the Streptococcus anginosus group, comprised of Streptococcus constellatus, Streptococcus intermedius, and Streptococcus anginosus, have emerged as clinically relevant in chronic airway infections in cystic fibrosis (CF) patients and have been implicated as etiologic agents of pulmonary exacerbation (6, 10, 13, 14). We have recently described the isolation of a large number of SMG strains from a cohort of CF patients by using the semiselective medium McKay agar (12). This collection of SMG respiratory isolates was not recovered by conventional CF microbiology and enabled us to characterize the phenotypic properties of airway isolates and compare them to invasive strains (5). These results, in combination with analysis of the nucleotide sequence of the 16S rRNA gene of these strains, revealed clusters of isolates that included both CF and invasive isolates with indistinguishable phenotypic characteristics (5, 9).

In this study, we evaluated whether patient-to-patient transmission was occurring in our CF patient cohort. The molecular epidemiological relationship of the SMG isolates was determined by using pulsed-field gel electrophoresis (PFGE) (4, 8, 15).

PFGE was performed by modification of a protocol described by Bartie et al. (2). The isolates were cultured at 37°C for 48 h on brain heart infusion agar supplemented with colistin sulfate (10 μg/ml) and oxolinic acid (5 μg/ml) under anaerobic conditions. The cells were harvested and suspended to 20% transmittance (600 nm) in 100 mM Tris-HCl buffer (pH 7.6). Mutanolysin (100 U; Sigma-Aldrich, St. Louis, MO) was added to 500 μl of cell suspension before an equal volume of molten 1% SeaKem Gold agarose (Lonza, Rockland, ME) was added. Plugs were cast at room temperature and then transferred to 1.5 ml of lysis solution (0.25 M EDTA [pH 9.0], 0.5% Brij 58, 2 g/liter sodium deoxycholate, 5 g/liter lauroyl sarcosine, 100 U/ml mutanolysin) and incubated at 37°C for 2 h. The lysis solution was replaced with 1.5 ml ESP solution (0.25 M EDTA [pH 9.5], 1% sodium lauroyl sarcosine, 0.5 mg/ml proteinase K) and incubated at 55°C for 2 h. The plugs were rinsed with 1 ml of distilled water and then washed for 10-min intervals, once with distilled water and three times with 1× Tris-EDTA (TE; 10 mM Tris-Hcl, 1 mM EDTA [pH 8.0]) at room temperature.

For restriction digestion, the plugs were preincubated in 300 μl of 1× reaction buffer (Invitrogen, Carlsbad, CA) at room temperature for 15 min and then replaced with fresh 1× reaction buffer supplemented with 90 U of SmaI or ApaI (New England BioLabs, Beverly, MA). SmaI and ApaI digestion occurred at room temperature and 31°C, respectively, for 4 h. Following digestion, the plugs were briefly rinsed twice in 1× TE. Following a 5-min wash in 1× TE, the plugs were loaded into a 1% SeaKem Gold agarose gel, prepared in 0.5× TBE (1× TBE is 89 mM Tris-HCl [pH 7.4], 89 mM boric acid, 25 mM EDTA [pH 8.0]). The following parameters were used: gradient, 6.0 V/cm; run time, 22 h; included angle, 120°; initial switch time, 10 s; and final switch time, 35 s at 14°C.

A database of the PFGE profiles was developed with BioNumerics software (Applied Maths, Saint-Martens-Latem, Belgium). Dendrograms were generated using the unweighted pair group method using average linkages with a 1.0% position tolerance and the Dice coefficient correlation. The threshold required to justify analysis with an additional restriction enzyme was 90%.

Fifty-nine unique profiles were observed from 76 SMG isolates cultured from expectorated sputum from 40 patients (Fig. 1). Such high genetic heterogeneity has been previously observed in the SMG (1). Four isolates from three patients were refractory to PFGE profiling.

Notably, only two isolates (M316 and C266) recovered from different patients clustered above 90% identity by SmaI profiling (Fig. 1). To further resolve whether these isolates might represent patient-to-patient transmission, we tested all available S. constellatus isolates recovered longitudinally from these two patients (two isolates from the patient whose sputum yielded isolate M316 and three isolates from the patient whose sputum yielded isolate C266) with a secondary restriction enzyme, ApaI (Fig. 2). This analysis revealed that these strains were in fact more genetically divergent and clustered at less than 80% identity. Given that these strains represent distinct PFGE profiles and that these two patients had not attended the clinic on the same day or been inpatients at the same time, the two strains appear to represent different strains.

PFGE revealed a diverse SMG population. Multiple SMG isolates per patient (collected either longitudinally or cross-sectionally) were analyzed from a total of 15 patients. Multiple PFGE profiles were detected in 11 patients (Fig. 1). Four of the patients with multiple SMG strains revealed intraspecies diversity; as many as three distinct strains of the same species were represented in a single patient (Fig. 1).

Isolates were available for longitudinal analysis in 7 of the 11 patients (63.6%) with multiple SMG strains present. In six of these cases (85.7%), at least one of the strains was isolated on at least two occasions. It was possible to investigate longitudinal isolates by PFGE in four additional patients. In total, the same isolate was recovered at multiple time points in 9 of the 11 patients (81.8%) analyzed longitudinally. As previously reported, this supports the hypothesis that chronic colonization is common (2, 13), although it may not always be the case.

The complex dynamics of SMG populations within certain patients was noteworthy. Examples of SMG populations in three patients that illustrate both the diversity within the SMG at the species and strain level and the complex population dynamics that can occur over time are shown in Fig. 3.

We have determined that SMG strains in our CF patient population are patient specific, and we have no evidence for the occurrence of patient-to-patient transmission. Intriguingly, this study reveals an unexpected level of complexity in SMG populations detected in sputum samples from certain CF patients. Moreover, it is important to consider that the intraspecies diversity we observe may still underrepresent the true population richness due to limited sampling. To fully appreciate the extent of genetic heterogeneity in chronic infections, deep sampling may be required. As we continue to investigate the CF airway microbiome, strain-level diversity and dynamics may be integral to developing predictive models of clinical perturbation.

FIG. 1.
  • Open in new tab
  • Download powerpoint
FIG. 1.

Relationship between all of the unique PFGE profiles generated with SmaI from the SMG isolates used in this study. Chronically colonizing strains (recovered from the same patient on multiple occasions) are indicated with an asterisk. Patients with multiple SMG strains are represented as vertical dotted lines to the right of the gel profiles; SMG isolates of different species are shown by a solid black circle. In patients where intraspecies diversity was observed, strains of the same species are depicted with solid black squares. The strain and species (S. anginosus [ANG], S. intermedius [INT], and S. constellatus [CON]) are indicated to the left and right of the gel profiles, respectively.

FIG. 2.
  • Open in new tab
  • Download powerpoint
FIG. 2.

ApaI fingerprints of multiple isolates from two patients with closely related SmaI profiles reveal that the strains are genetically different enough to rule out patient-to-patient transmission. The multiple isolates were recovered at different times (shown in days to the right of the gel profile). The two isolates indicated with an asterisk are also represented in Fig. 1.

FIG. 3.
  • Open in new tab
  • Download powerpoint
FIG. 3.

Genetic relatedness of strains recovered from three different patients (A, B, and C) that demonstrate inter- and intraspecies diversity. Population dynamics of the SMG strains from longitudinal sampling are shown next to the corresponding PFGE profile. Strains of the same or different species are depicted with solid black squares or solid black circles, respectively. The strain and species (S. anginosus [ANG], S. intermedius [INT], and S. constellatus [CON]) are indicated to the left and right of the gel profiles, respectively. The isolates indicated with an asterisk are also represented in Fig. 1.

ACKNOWLEDGMENTS

We acknowledge the staff of the Southern Alberta CF Clinic for their contribution to patient care and for providing epidemiological data.

This work was supported by grants from the Canadian Cystic Fibrosis Foundation (CCFF) and the Canadian Institutes of Health Research (CIHR) to M.G.S. M.G.S. is supported as an Alberta Heritage Foundation for Medical Research (AHFMR) Scientist and Canada Research Chair in Microbial Gene Expression. An AHFMR studentship and a Canada Graduate Scholarship from CIHR support C.D.S. M.E.G. is supported by studentships from the CIHR, CCFF, and AHFMR.

FOOTNOTES

    • Received 27 February 2010.
    • Returned for modification 16 April 2010.
    • Accepted 3 May 2010.
  • Copyright © 2010 American Society for Microbiology

REFERENCES

  1. 1.↵
    Asmah, N., B. Eberspacher, T. Regnath, and M. Arvand. 2009. Prevalence of erythromycin and clindamycin resistance among clinical isolates of the Streptococcus anginosus group in Germany. J. Med. Microbiol. 58 : 222-227.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    Bartie, K. L., M. J. Wilson, D. W. Williams, and M. A. Lewis. 2000. Macrorestriction fingerprinting of “Streptococcus milleri” group bacteria by pulsed-field gel electrophoresis. J. Clin. Microbiol. 38 : 2141-2149.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    Belko, J., D. A. Goldmann, A. Macone, and A. K. Zaidi. 2002. Clinically significant infections with organisms of the Streptococcus milleri group. Pediatr. Infect. Dis. J. 21 : 715-723.
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    Bert, F., C. Branger, and N. Lambert-Zechovsky. 1997. Pulsed-field gel electrophoresis is more discriminating than multilocus enzyme electrophoresis and random amplified polymorphic DNA analysis for typing pyogenic streptococci. Curr. Microbiol. 34 : 226-229.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    Grinwis, M. E., C. D. Sibley, M. D. Parkins, C. S. Eshaghurshan, H. R. Rabin, and M. G. Surette. 2009. Characterization of Streptococcus milleri group isolates from expectorated sputum of adult cystic fibrosis patients. J. Clin. Microbiol. 48 : 395-401.
    OpenUrlCrossRefPubMed
  6. 6.↵
    Harris, J. K., M. A. De Groote, S. D. Sagel, E. T. Zemanick, R. Kapsner, C. Penvari, H. Kaess, R. R. Deterding, F. J. Accurso, and N. R. Pace. 2007. Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis. Proc. Natl. Acad. Sci. U. S. A. 104 : 20529-20533.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    Maskell, N. A., C. W. Davies, A. J. Nunn, E. L. Hedley, F. V. Gleeson, R. Miller, R. Gabe, G. L. Rees, T. E. Peto, M. A. Woodhead, D. J. Lane, J. H. Darbyshire, and R. J. Davies for the First Multicenter Intrapleural Sepsis Trial (MIST1) Group. 2005. U.K. controlled trial of intrapleural streptokinase for pleural infection. N. Engl. J. Med. 352 : 865-874.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    Moser, S. A., S. C. Mitchell, J. D. Ruby, S. Momeni, R. C. Osgood, J. Whiddon, and N. K. Childers. 2010. Repetitive extragenic palindromic PCR for study of Streptococcus mutans diversity and transmission in human populations. J. Clin. Microbiol. 48 : 599-602.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    Olson, A. B., C. D. Sibley, L. Schmidt, M. A. Wilcox, M. G. Surette, and C. R. Corbett. 2010. Development of real-time PCR assays for detection of the Streptococcus milleri group from cystic fibrosis clinical specimens using targets for cpn60 and 16S rRNA genes. J. Clin. Microbiol. 48 : 1150-1160.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    Parkins, M. D., C. D. Sibley, M. G. Surette, and H. R. Rabin. 2008. The Streptococcus milleri group-an unrecognized cause of disease in cystic fibrosis: a case series and literature review. Pediatr. Pulmonol. 43 : 490-497.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    Prasad, K. N., A. M. Mishra, D. Gupta, N. Husain, M. Husain, and R. K. Gupta. 2006. Analysis of microbial etiology and mortality in patients with brain abscess. J. Infect. 53 : 221-227.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    Sibley, C. D., M. Grinwis, T. R. Field, M. D. Parkins, J. C. Noorgard, D. B. Gregson, H. R. Rabin, and M. Surette. 2010. McKay agar enables routine quantification of the Streptococcus milleri group in cystic fibrosis patients. J. Med. Microbiol. 59 : 534-540.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    Sibley, C. D., M. D. Parkins, H. R. Rabin, K. Duan, J. C. Norgaard, and M. G. Surette. 2008. A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients. Proc. Natl. Acad. Sci. U. S. A. 105 : 15070-15075.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    Sibley, C. D., M. D. Parkins, H. R. Rabin, and M. G. Surette. 2009. The relevance of the polymicrobial nature of airway infection in the acute and chronic management of patients with cystic fibrosis. Curr. Opin. Investig. Drugs 10 : 787-794.
    OpenUrlPubMed
  15. 15.↵
    Soll, D. R., C. Pujol, and S. R. Lockhart. 2007. Laboratory procedures for epidemiological analysis of microorganisms, p. 129-151. In P. R. Murray, E. J. Baron, J. H. Jorgensen, M. L. Landry, and M. A. Pfaller (ed.), Manual of clinical microbiology, 9th ed., vol. 1. ASM Press, Washington, DC.
    OpenUrl
PreviousNext
Back to top
Download PDF
Citation Tools
The Streptococcus milleri Population of a Cystic Fibrosis Clinic Reveals Patient Specificity and Intraspecies Diversity
Christopher D. Sibley, Kristen A. Sibley, Tara A. Leong, Margot E. Grinwis, Michael D. Parkins, Harvey R. Rabin, Michael G. Surette
Journal of Clinical Microbiology Jun 2010, 48 (7) 2592-2594; DOI: 10.1128/JCM.00414-10

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Streptococcus milleri Population of a Cystic Fibrosis Clinic Reveals Patient Specificity and Intraspecies Diversity
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The Streptococcus milleri Population of a Cystic Fibrosis Clinic Reveals Patient Specificity and Intraspecies Diversity
Christopher D. Sibley, Kristen A. Sibley, Tara A. Leong, Margot E. Grinwis, Michael D. Parkins, Harvey R. Rabin, Michael G. Surette
Journal of Clinical Microbiology Jun 2010, 48 (7) 2592-2594; DOI: 10.1128/JCM.00414-10
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

cystic fibrosis
Streptococcal Infections
Streptococcus milleri Group

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X